Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Coronary Disease peptide trials
3 selected ClinicalTrials.gov records carrying the official condition label Coronary Disease. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
3 selected records.
2 profiles.
2010–2014 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 60 selected PubMed records and 29 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Coronary Disease unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00262054
PeptideScanner retained ClinicalTrials.gov record NCT00262054 at 2026-11-15T21:58:19.888Z. Its registry update date was 2010-03-15, and PeptideScanner's reviewed identity mapping was bivalirudin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- March 15, 2010
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00317395
PeptideScanner retained ClinicalTrials.gov record NCT00317395 at 2026-11-15T21:59:29.646Z. Its registry update date was 2014-12-03, and PeptideScanner's reviewed identity mapping was eptifibatide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- December 3, 2014
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00373451
PeptideScanner retained ClinicalTrials.gov record NCT00373451 at 2026-11-15T21:58:19.888Z. Its registry update date was 2012-05-08, and PeptideScanner's reviewed identity mapping was bivalirudin.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- May 8, 2012
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Eptifibatide · 2014-12-03
ClinicalTrials.gov record NCT00317395
Completed at the retained observation.
Open attributed record →Bivalirudin · 2012-05-08
ClinicalTrials.gov record NCT00373451
Completed at the retained observation.
Open attributed record →Bivalirudin · 2010-03-15
ClinicalTrials.gov record NCT00262054
Completed at the retained observation.
Open attributed record →